(Q28191643)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Coronary heart disease in the statin and aspirin era: are results of clinical trials being put into practice? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference

coronary artery disease

1 reference

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

C G Missouris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

R G Kalaitzidis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

N Parchure

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

S Ziakka

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

D Ward

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

language of work or name

English

0 references

publication date

1 December 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Internal Medicine

3 December 2019

published in

2 references

PubMed

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

490-495

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT).

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events).

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

EUROASPIRE. A European Society of Cardiology survey of secondary prevention of coronary heart disease: principal results. EUROASPIRE Study Group. European Action on Secondary Prevention through Intervention to Reduce Events

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorvastatin versus Revascularization Treatment Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Drug therapy for coronary heart disease: the Sheffield table

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Sheffield risk and treatment table for primary prevention of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

The use of HMG Co-A reductase inhibitors following acute myocardial infarction in hospital practice

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on coronary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Effect of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the coronary artery surgery study (CASS): 10-Year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

In pursuit of quality: the National Institute for Clinical Excellence

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

Persistence of use of lipid-lowering medications: a cross-national study

1 reference

https://api.crossref.org/works/10.1016%2FS0953-6205%2801%2900171-6

7 January 2021

10.1016/S0953-6205(01)00171-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11711271%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference